Researcher interests: Development of an anti-metastatic, peptidomimetic drug based on alpha1/alpha2 integrin receptor inhibition. Investigations of tissue engineered scaffolds containing human umbilical cord blood stem cells for therapy of neurological disorders. Development of in vitro colon cancer models for near infrared imaging. Characterization in vitro and in vivo of novel angiogenic functions of nerve growth factor (NGF). The role of NGF in muscle degeneration. Isolation and characterization of anti-cancer and anti-angiogenic lead compounds from snake venoms.
FACULTY / SCHOOL: School of Medicine - IMRIC
Contact Business Development: Shani Bullock

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: